| CAS NO: | 88979-61-7 |
| 包装 | 价格(元) |
| 1mg | 电议 |
| 5mg | 电议 |
| 10mg | 电议 |
| 50mg | 电议 |
| 生物活性 | Bafilomycin C1 is amacrolideantibioticisolated fromStreptomyces sp. Bafilomycin C1 is a potent, specific and reversible inhibitor ofvacuolar-type H+-ATPases (V-ATPases). Bafilomycin C1 inhibits growth of gram-positivebacteriaandfungi[2]. Bafilomycin C1 induces cellapoptosisand can be used for the study of hepatocellular carcinoma (HCC)[2]. | ||||||||||||||||||||||||
| IC50& Target |
| ||||||||||||||||||||||||
| 体外研究 (In Vitro) | Bafilomycin C1 (0.33-10 μM; 6 days) inhibits the growth and proliferation of SMMC7721 and HepG2 cells in a timeand dose-dependent manner[2].Bafilomycin C1 (0.33-3.3 μM; 24 hours) decreases cyclin D3, cyclin E1, CDK2, CDK4, and CDK6 expression in both mRNA and protein expression in SMMC7721 cells[2].Bafilomycin C1 (3.3-10 μM; 24 hours) causes morphological alterations and increases the population of apoptotic cells by Hoechst 33258 (HY-15558) staining compared to vehicle[2]. Cell Viability Assay[2]
Western Blot Analysis[2]
Apoptosis Analysis[2]
| ||||||||||||||||||||||||
| 体内研究 (In Vivo) | Bafilomycin C1 (subcutaneous injection; 0.2 mg/kg; 20 days) retards the tumor growth without apparent adverse reactions or side effects in nude mice model[1].
| ||||||||||||||||||||||||
| 分子量 | 720.89 | ||||||||||||||||||||||||
| 性状 | Solid | ||||||||||||||||||||||||
| Formula | C39H60O12 | ||||||||||||||||||||||||
| CAS 号 | 88979-61-7 | ||||||||||||||||||||||||
| 中文名称 | 巴菲霉素C1 | ||||||||||||||||||||||||
| 结构分类 |
| ||||||||||||||||||||||||
| 来源 | Streptomyces sp | ||||||||||||||||||||||||
| 运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||||||||||
| 储存方式 | -20°C, sealed storage, away from moisture *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) | ||||||||||||||||||||||||
| 溶解性数据 | In Vivo:
|
